MedTrace Logo

A Study of the Effectiveness of Electronic Interventions on the Standardized Prescription Benzodiazepines and Z-drugs

NCT03724669 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2022-03-10

No results posted yet for this study

Summary

A retrospective surveys and group interviews focusing on the prescription and abuse of benzodiazepines will be carried out in China. Based the results of retrospective surveys and group interviews and guidelines of benzodiazepines and Z-drugs standardized use, a real-world randomized control trial of would be carried to evaluate the effectiveness of the intervention of using electronic content push in reducing the use rate of psychiatric BZDs and Z-drugs and improving clinical efficiency.

Conditions

  • Bcenzodiazepines, Abuse, Retrospective Study, Focus Groups, Real-world Study

Interventions

BEHAVIORAL

waiting list

After the study ends, they will have access to receive the educational texts and view the online lectures.

BEHAVIORAL

benzodiazepines related knowledge intervention

participants receiving 11 articles pushing and 3 online lectures through the electronic interventions App, once a week, last for 3 months

Sponsors & Collaborators

  • Second Xiangya Hospital of Central South University

    collaborator OTHER

  • West China Hospital

    collaborator OTHER

  • Suzhou Psychiatric Hospital, The Affiliated Guangji Hospital of Soochow University

    collaborator UNKNOWN

  • Wuhan Mental Health Centre

    collaborator OTHER

  • Shanghai Mental Health Center

    lead OTHER

Principal Investigators

  • Na Zhong, Doctor · Shanghai Mental Health Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-10
Primary Completion
2021-06-30
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03724669 on ClinicalTrials.gov